Biocryst Pharmaceuticals reported $-49957000 in Operating Profit for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
DBV Technologies DBVT:US -16771000 3.29M
Alnylam Pharmaceuticals ALNY:US $ -146.73M 47.83M
Biocryst Pharmaceuticals BCRX:US $ -49.96M 53.62M
Chemocentryx CCXI:US $ -38.23M 1.82M
Chugai Pharma 4519:JP Y 187007M 47945M
Daiichi Sankyo 4568:JP Y -50747M 89777M
Enanta Pharmaceuticals ENTA:US $ -33.85M 3.44M
Gilead Sciences GILD:US $ 197M 743M
GlaxoSmithKline GSK:LN 2.8B 1.91B
Glaxosmithkline GSK:US $ 2801M 1906M
Intra Cellular Therapies ITCI:US $ -72.66M 13.34M
IONIS PHARMACEUT IONS:US $ -57.5M 278.11M
Karyopharm Therapeutics KPTI:US $ -34586000 81.55M
Mirati Therapeutics MRTX:US $ -184.22M 12.86M
Neurocrine Biosciences NBIX:US $ 3.1M 39.4M
Novavax NVAX:US $ 209.29M 1034.26M
Ptc Therapeutics PTCT:US $ -86.52M 1.79M
Regeneron Pharmaceuticals REGN:US $ 1258.5M 1381.2M
Sarepta Therapeutics SRPT:US $ -86.88M 18.93M
Ultragenyx Pharmaceutical RARE:US $ -136.63M 34.07M
Vertex Pharmaceuticals VRTX:US $ 1040.9M 163.18M
YTE INCY:US $ 116.54M 5.81M